COVID-19 vaccines effective against variants, experts say

February 4, 2021
 

Like annual flu shots, the COVID-19 vaccines strongly protect against multiple strains of coronavirus and show reduced but still significant efficacy against newer variants, infectious diseases specialists from UT Health San Antonio said.



Novavax vaccine

As variants make the news, COVID-19 vaccines are still effective and precautions are still needed, experts say

February 3, 2021
 

Getting COVID-19 vaccines into arms and continuing to mask and social distance is essential as cases associated with U.K., South Africa and Brazil coronavirus variants crop up in the U.S., infectious disease specialists from UT Health San Antonio said Wednesday. News that vaccine efficacy is reduced against the variant strains must not deter the public […]




Take action: Find out if you have implicit bias and what to do next!

February 3, 2021
 

Discover your biases with the “Find Out If You Have Implicit Bias and What to Do Next” Action Pack from the Salud America! program at UT Health San Antonio.




Mays Cancer Center joins leading cancer organizations to warn cancer doesn’t stop for COVID-19 and neither should you

January 28, 2021
 

The coalition of 76 organizations has released an open letter reminding the public that cancer still poses a major threat to people’s health, and acting as soon as is safely possible can lead to much better outcomes in the future.



Erase Cancer

Mays Cancer Center joins leading cancer organizations to warn cancer doesn’t stop for COVID-19 and neither should you

January 28, 2021
 

The Mays Cancer Center, home to UT Health San Antonio MD Anderson, is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic. The coalition of 76 organizations has […]




New England Journal of Medicine publishes COVID-19 treatment trial results

January 27, 2021
 

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health found that a combination of the drugs baricitinib and remdesivir reduced time to recovery.